{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:39:10Z","timestamp":1782603550765,"version":"3.54.5"},"reference-count":31,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2001,12,25]],"date-time":"2001-12-25T00:00:00Z","timestamp":1009238400000},"content-version":"vor","delay-in-days":693,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Transplantation"],"published-print":{"date-parts":[[2000,2]]},"abstract":"<jats:p>Background: There is controversy whether high\u2010dose chemotherapy and a blood cell or bone marrow autotransplant is a better treatment than conventional\u2010dose chemotherapy for women with local\/regional or metastatic breast cancer. Subject selection and time\u2010to\u2010treatment biases make definitive comparison impossible. Recent results of randomized trials are contradictory.Objective: Determine appropriateness of high\u2010dose chemotherapy and a blood cell or bone marrow autotransplant in women with breast cancer.Panelists: Nine breast cancer experts from diverse geographic sites and practice settings.Evidence: Boolean MEDLINE searches of \u2018breast cancer\u2019 and \u2018chemotherapy\u2019 and\/or \u2018blood cell\u2019 or \u2018bone marrow transplants\u2019.Process: We used a modified Delphi\u2010panel group judgement process. Clinical variables were permuted to define 2058 clinical settings. Each panelist rated appropriateness of high\u2010dose therapy and an autotransplant versus conventional therapy on a 9\u2010point ordinal scale (1: most inappropriate, 9: most appropriate). An appropriateness index was developed based on median rating and amount of disagreement. The relationship of appropriateness indices to the permuted clinical variables was considered by analysis of variance and recursive partitioning.Conclusions: In women with local\/regional breast cancer autotransplants were rated: 1) appropriate in those with \u226510 cancer\u2010involved lymph nodes; 2) uncertain in those with 4\u20139 cancer\u2010involved nodes; and 3) inappropriate in women with \u22643 cancer\u2010involved lymph nodes. In women with metastatic breast cancer autotransplants were rated: 1) appropriate in those with metastases to \u2018favorable\u2019 sites (skin, lymph node, pleura) and a complete or partial response to chemotherapy; 2) uncertain in women with metastases to \u2018unfavorable\u2019 sites (lung, liver, or central nervous system) and a complete response to chemotherapy or those with bone metastases and a complete or partial response or stable disease after chemotherapy; and 3) inappropriate in other settings.<\/jats:p>","DOI":"10.1034\/j.1399-0012.2000.140107.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T13:45:51Z","timestamp":1047390351000},"page":"32-41","source":"Crossref","is-referenced-by-count":20,"title":["Delphi\u2010panel analysis of appropriateness of high\u2010dose chemotherapy and blood cell or bone marrow autotransplants in women with breast cancer"],"prefix":"10.1111","volume":"14","author":[{"given":"Robert Peter","family":"Gale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolla","family":"Edward Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Dubois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob D","family":"Bitran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aman","family":"Buzdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Hortobagyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen E","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary S","family":"Lazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Spitzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra M","family":"Swain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarence B","family":"Vaughn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles E","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvana","family":"Martino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2001,12,25]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0266462300002774"},{"key":"e_1_2_7_3_2","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1001\/jama.1993.03500060053030","article-title":"The appropriateness of use of coronary artery bypass surgery in New York State","volume":"269","author":"Leape LL","year":"1993","journal-title":"JAMA"},{"key":"e_1_2_7_4_2","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1001\/jama.1993.03500060066032","article-title":"The appropriateness of use of coronary artery bypass surgery in New York State","volume":"269","author":"Bernstein SJ","year":"1993","journal-title":"JAMA"},{"key":"e_1_2_7_5_2","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1001\/jama.1993.03500180090040","article-title":"The appropriateness of hysterectomy; a comparison of care in seven health plans","volume":"269","author":"Bernstein SJ","year":"1993","journal-title":"JAMA"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)91196-H"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.271.16.1260"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199806253382607"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1997.15.5.1870"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)79310-7"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-125-7-199610010-00010"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.3-5-289"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)01350-6"},{"key":"e_1_2_7_14_2","first-page":"A417","article-title":"Lack of efficacy of adjuvant high\u2010dose (HD) tandem combination chemotherapy (CT) for high\u2010risk primary breast cancer (HRPBC): a randomized trial","volume":"17","author":"Hortobagyi GN","year":"1998","journal-title":"Proceed Ann Meet Am Soc Clin Oncol"},{"key":"e_1_2_7_15_2","first-page":"2A","article-title":"Randomized controlled trial of high dose chemotherapy (HD\u2010CNVp) versus standard dose (CAF) chemotherapy fr high risk, surgically treated, primary breast cancer","volume":"18","author":"Bezwoda WR","year":"1999","journal-title":"Proceed Ann Meet Am Soc Clin Oncol"},{"key":"e_1_2_7_16_2","first-page":"1A","article-title":"A prospective, randomized comparison of two doses of combination alkylating agents (AA) as consolidation after CAF in high\u2010risk primary breast cancer involving tenor more axillary lymph nodes (LN): preliminary results of CALGB 9082\/SWOG 9114\/NCIC MA\u201013","volume":"18","author":"Peters W","year":"1999","journal-title":"Proceed Ann Meet Am Soc Clin Oncol"},{"key":"e_1_2_7_17_2","first-page":"2A","article-title":"Results from a randomized adjuvant breast cancer study with high dose chemotherapy with CTCb supported by autologous bone marrow stem cells versus dose escalated and tailored FEC therapy","volume":"18","author":"The Scandinavian Breast Cancer Study Group 9401","year":"1999","journal-title":"Proceed Ann Meet Am Soc Clin Oncol"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199410203311602"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199410203311601"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1995.13.10.2483"},{"key":"e_1_2_7_21_2","first-page":"1A","article-title":"Phase III randomized trial high\u2010dose chemotherapy (HDC) and stem cell support (SCT) shows no difference in overall survival or severe toxicity compared to maintenance chemotherapy with cyclophosphamide, methotrexate and 5\u2010fluorouracil (CMF) for women with metastatic breast cancer who are responding to conventional induction chemotherapy: the \u2018Philadelphia\u2019 Intergroup Study (PBT\u20101)","volume":"18","author":"Stadtmauer EA","year":"1999","journal-title":"Proceed Ann Meet Am Soc Clin Oncol"},{"key":"e_1_2_7_22_2","first-page":"A149","article-title":"A large, prospective, randomized trial of high\u2010dose combination alkylating agents (CPB) with autologous cellular support (ABMS) as consolidation for patients with metastatic breast cancer achieving complete remission after intensive doxorubicin\u2010based induction therapy (AFM)","volume":"15","author":"Peters WP","year":"1996","journal-title":"Proceed Ann Meet Am Soc Clin Oncol."},{"key":"e_1_2_7_23_2","first-page":"128A","article-title":"Conventional\u2010 versus high\u2010dose therapy for metastatic breast cancer: comparison of cancer and Leukemia Group B (CALGB) and the Blood and Marrow Transplant Registry (ABMTR) patients","volume":"18","author":"Berry DA","year":"1999","journal-title":"Proceed Ann Meet Am Soc Clin Oncol"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198803243181201"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.76.7.766"},{"key":"e_1_2_7_26_2","first-page":"59","volume-title":"Clinical practice guideline development: methodology perspectives. US Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research, Office of the Forum for Quality and Effectiveness in Health Care. Rockville, MD; Pub. No. 95\u20100009; also available as Brook RH. The RAND\/UCLA appropriateness method: Rand\/RP\u2010395","author":"Brook RH","year":"1994"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.77.2.187"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0266462300012022"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199612193352506"},{"key":"e_1_2_7_30_2","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1001\/jama.1995.03530080048040","article-title":"Validity of criteria used for detecting underuse of coronary revascularization","volume":"274","author":"Kravitz RL","year":"1995","journal-title":"J Am Med Ass"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)90120-5"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)09102-8"}],"container-title":["Clinical Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1399-0012.2000.140107.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1399-0012.2000.140107.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1034\/j.1399-0012.2000.140107.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T17:48:21Z","timestamp":1698601701000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1034\/j.1399-0012.2000.140107.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,2]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,2]]}},"alternative-id":["10.1034\/j.1399-0012.2000.140107.x"],"URL":"https:\/\/doi.org\/10.1034\/j.1399-0012.2000.140107.x","archive":["Portico"],"relation":{},"ISSN":["0902-0063","1399-0012"],"issn-type":[{"value":"0902-0063","type":"print"},{"value":"1399-0012","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,2]]}}}